Article

FDA clearance granted for femtosecond laser

A new femtosecond laser (iFS, Advanced Medical Optics), which, according to its manufacturer is capable of creating a corneal flap during LASIK in less than 10 seconds, has received FDA clearance.

Santa Ana, CA-A new femtosecond laser (iFS, Advanced Medical Optics), which, according to its manufacturer is capable of creating a corneal flap during LASIK in less than 10 seconds, has received FDA clearance. It has been designed to increase postoperative flap adhesion and enhance the biomechanical stability of the post-LASIK cornea.

Some additional features of the laser, according to the company, include a higher repetition rate, tighter spot separation, lower energy, a high-resolution digital video microscope, a new user interface, a keyboard and touch screen, and ergonomic design for maximum surgeon comfort.

"The . . . laser builds upon an 8-year history of innovation and more than two million IntraLase femtosecond procedures performed worldwide," said American Medical Optics (AMO) chairman and chief executive officer Jim Mazzo. "This technology is an integral part of AMO?s proprietary iLASIK technology suite and a tangible example of our commitment to not only maintain a substantial advantage over competing systems, but also to provide technologies that advance the standard of vision care medically."

"The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy with capabilities such as the elliptical flap option, inverted bevel-in side cut angle, and increased speed," said Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute in San Diego. "This exciting new laser, combined with the iLASIK technology suite, provides the surgeon with the most advanced technologies to give their patients the safest and best outcomes."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.